4.4(top 3%)
Impact Factor
4.8(top 3%)
extended IF
173(top 1%)
H-Index
6.8K
authors
10.1K
papers
335.3K
citations
8.5K
citing journals
106.6K
citing authors

Most Cited Articles of Breast Cancer Research and Treatment

TitleYearCitations
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients20101.9K
The Nottingham Prognostic Index in primary breast cancer1992792
Epidemiology of basal-like breast cancer2008651
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis2010638
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses2008631
REporting recommendations for tumor MARKer prognostic studies (REMARK)2006604
Relevance of breast cancer cell lines as models for breast tumours: an update2004602
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu1992596
Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors1995578
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation2001539
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer2011533
Differentiation of the mammary gland and susceptibility to carcinogenesis1982532
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients2016507
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen2007470
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer2008425
Breast cancer survivors: psychosocial concerns and quality of life1996418
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study2008417
Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database2002408
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review2012383
Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen2004378
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer2014375
Targeting breast stem cells with the cancer preventive compounds curcumin and piperine2010372
Role of epidermal growth factor receptor in breast cancer2012371
Pattern of metastatic spread in triple-negative breast cancer2009369
The role of vascular endothelial growth factor in pathological angiogenesis1995363